Showing results (421-430 of 502) with videos related to
Sort By:
Pageof 51
The American Journal of Cardiology|March 10, 2025
Hemolytic Anemia Following SAPIEN 3 Ultra RESILIA Implantation (from the OCEAN-TAVI Registry)Kenichi Ishizu, Shinichi Shirai, Masaomi Hayashi, et al.The American Journal of Cardiology|September 9, 2021
Effect of Polypharmacy on Long-Term Mortality After Percutaneous Coronary InterventionKo Yamamoto, Masahiro Natsuaki, Takeshi Morimoto, et al.ESC Heart Failure|May 16, 2024
Development of interpretable machine learning models to predict in-hospital prognosis of acute heart failure patientsMunekazu Tanaka, Hirohiko Kohjitani, Erika Yamamoto, et al.Journal of the American Heart Association|June 23, 2026
Sex Differences in Characteristics and Outcomes Among Patients With Hypertrophic Cardiomyopathy: Insights From the REVEAL-HCM StudyMasayuki Nakamura, Haruhiko Abe, Yasunori Ueda, et al.JAMA Network Open|June 22, 2019
Association of Mineralocorticoid Receptor Antagonist Use With All-Cause Mortality and Hospital Readmission in Older Adults With Acute Decompensated Heart FailureHidenori Yaku, Takao Kato, Takeshi Morimoto, et al.ESC Heart Failure|July 25, 2020
Sex differences in patients with acute decompensated heart failure in Japan: observation from the KCHF registryErika Yamamoto, Takao Kato, Hidenori Yaku, et al.BMJ (Clinical Research Ed.)|June 17, 2021
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trialsMarco Valgimigli, Felice Gragnano, Mattia Branca, et al.European Heart Journal. Quality of Care & Clinical Outcomes|August 7, 2019
A risk prediction model in asymptomatic patients with severe aortic stenosis: CURRENT-AS risk scoreEri Minamino-Muta, Takao Kato, Takeshi Morimoto, et al.Journal of the American College of Cardiology|February 8, 2023
P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary InterventionsFelice Gragnano, Roxana Mehran, Mattia Branca, et al.JAMA Cardiology|March 2, 2022
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome: The STOPDAPT-2 ACS Randomized Clinical TrialHirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki, et al.Pageof 51